Left ventricular assist devices (LVADs) are an increasingly common treatment for end-stage systolic heart failure. However, there are limited data on how to best treat patients pharmacologically after LVAD implantation, resulting in uncertainty about which heart failure medications provide the most benefit. Still, some evidence exists that certain medical therapies can prevent remodeling and improve right ventricular and, possibly, left ventricular function. This article reviews the current literature for medical heart failure therapy in LVAD patients, and possible future treatment strategies.

作者：John J, Rommel；Thomas J, O'Neill；Anton, Lishmanov；Jason N, Katz；Patricia P, Chang

来源：Heart failure clinics 2014 年 10卷 4期